Interleukin-7 (IL-7)-induced proliferation of CD8+ T-chronic lymphocytic leukemia cells
- PMID: 1532802
- DOI: 10.1007/BF00918139
Interleukin-7 (IL-7)-induced proliferation of CD8+ T-chronic lymphocytic leukemia cells
Abstract
Interleukin-7 (IL-7) is a growth factor for pro-B cells, pre-B cells, and thymocytes and is known to induce the proliferation of normal human peripheral T cells. Moreover, human B and T acute leukemia cells with immature surface markers proliferate in response to IL-7. Here we describe a case of T-chronic lymphocytic leukemia, in which the leukemic cells showed a proliferative response to human recombinant IL-7 in vitro. The patient was a 74-year-old woman with anemia and thrombocytopenia, whose bone marrow was fibrosed and infiltrated with pathologic cells. Surface markers of the leukemic cells were CD2(+), CD3(+), CD5(+), CD7(+), CD8(+), and CD4(-). Both T-cell receptor beta-chain and gamma-chain genes were found to be rearranged by immunogenotypic analysis. The leukemic cells proliferated in response to IL-7 dose dependently. The DNA synthesis of CLL cells was stimulated by not only IL-7 but also IL-2 and IL-4. The IL-7-induced proliferation was not inhibited by antibodies to IL-2 receptors or the anti-IL-4 antibody. These findings indicate that IL-7 may induce the proliferation of peripheral CD8+ T cells, even on its pathological counterpart.
Similar articles
-
Leukemic cells from a chronic T-lymphocytic leukemia patient proliferated in response to both interleukin-2 and interleukin-4 without prior stimulation and produced interleukin-2 mRNA with stimulation.Blood. 1988 Oct;72(4):1177-81. Blood. 1988. PMID: 3262382
-
A patient of CD4-/CD8+ chronic T-cell leukemia associated with hypercalcemia.Leuk Res. 1991;15(1):43-9. doi: 10.1016/0145-2126(91)90143-h. Leuk Res. 1991. PMID: 1825509
-
T cell growth-promoting activity of interferon-gamma. Mitogenic effect of the recombinant cytokine on cells from a human T-chronic lymphocytic leukemia.Leukemia. 1994 Aug;8(8):1294-300. Leukemia. 1994. PMID: 8057665
-
True small lymphocytic T-cell chronic lymphocytic leukemia lacking the CD3 molecule and TCR-alpha beta on its cell surface.Int J Hematol. 1999 Oct;70(3):169-73. Int J Hematol. 1999. PMID: 10561909
-
Immunobiology of chronic lymphocytic leukemia.Hematol Oncol Clin North Am. 1990 Apr;4(2):405-29. Hematol Oncol Clin North Am. 1990. PMID: 2182599 Review.
Cited by
-
Treatment with soluble interleukin-15Ralpha exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response.J Exp Med. 2002 Jun 3;195(11):1463-70. doi: 10.1084/jem.20011915. J Exp Med. 2002. PMID: 12045244 Free PMC article.
-
Potential implications of interleukin-7 in chronic wound healing.Exp Ther Med. 2016 Jul;12(1):33-40. doi: 10.3892/etm.2016.3263. Epub 2016 Apr 18. Exp Ther Med. 2016. PMID: 27347014 Free PMC article.
-
Genetically engineered mesenchymal stem cells: targeted delivery of immunomodulatory agents for tumor eradication.Cancer Gene Ther. 2020 Dec;27(12):854-868. doi: 10.1038/s41417-020-0179-6. Epub 2020 May 18. Cancer Gene Ther. 2020. PMID: 32418986 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials